These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The use of surface plasmon resonance (SPR) and fluorescence resonance energy transfer (FRET) to monitor the interaction of the plant G-proteins Ms-Rac1 and Ms-Rac4 with GTP. Brecht M; Sewald K; Schiene K; Keen G; Fricke M; Sauer M; Niehaus K J Biotechnol; 2004 Aug; 112(1-2):151-64. PubMed ID: 15288950 [TBL] [Abstract][Full Text] [Related]
4. Selective activation by the guanine nucleotide exchange factor Don1 is a main determinant of Cdc42 signalling specificity in Ustilago maydis. Hlubek A; Schink KO; Mahlert M; Sandrock B; Bölker M Mol Microbiol; 2008 May; 68(3):615-23. PubMed ID: 18394145 [TBL] [Abstract][Full Text] [Related]
5. Suppression of nuclear Wnt signaling leads to stabilization of Rac1 isoforms. Esufali S; Charames GS; Bapat B FEBS Lett; 2007 Oct; 581(25):4850-6. PubMed ID: 17888911 [TBL] [Abstract][Full Text] [Related]
6. Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation. Singh A; Karnoub AE; Palmby TR; Lengyel E; Sondek J; Der CJ Oncogene; 2004 Dec; 23(58):9369-80. PubMed ID: 15516977 [TBL] [Abstract][Full Text] [Related]
7. Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors. Jordan P; Brazåo R; Boavida MG; Gespach C; Chastre E Oncogene; 1999 Nov; 18(48):6835-9. PubMed ID: 10597294 [TBL] [Abstract][Full Text] [Related]
8. Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1). Asano Y; Kitamura S; Ohra T; Aso K; Igata H; Tamura T; Kawamoto T; Tanaka T; Sogabe S; Matsumoto S; Yamaguchi M; Kimura H; Itoh F Bioorg Med Chem; 2008 Apr; 16(8):4715-32. PubMed ID: 18313304 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity. Navarrete-Vazquez G; Paoli P; León-Rivera I; Villalobos-Molina R; Medina-Franco JL; Ortiz-Andrade R; Estrada-Soto S; Camici G; Diaz-Coutiño D; Gallardo-Ortiz I; Martinez-Mayorga K; Moreno-Díaz H Bioorg Med Chem; 2009 May; 17(9):3332-41. PubMed ID: 19362487 [TBL] [Abstract][Full Text] [Related]
10. Exploring the active site of phenylethanolamine N-methyltransferase with 3-hydroxyethyl- and 3-hydroxypropyl-7-substituted-1,2,3,4-tetrahydroisoquinolines. Grunewald GL; Romero FA; Seim MR; Criscione KR; Deupree JD; Spackman CC; Bylund DB Bioorg Med Chem Lett; 2005 Feb; 15(4):1143-7. PubMed ID: 15686930 [TBL] [Abstract][Full Text] [Related]
11. Role of Rac 1 and cAMP in endothelial barrier stabilization and thrombin-induced barrier breakdown. Baumer Y; Spindler V; Werthmann RC; Bünemann M; Waschke J J Cell Physiol; 2009 Sep; 220(3):716-26. PubMed ID: 19472214 [TBL] [Abstract][Full Text] [Related]
12. Virtual screening approach for the identification of new Rac1 inhibitors. Ferri N; Corsini A; Bottino P; Clerici F; Contini A J Med Chem; 2009 Jul; 52(14):4087-90. PubMed ID: 19527032 [TBL] [Abstract][Full Text] [Related]
13. Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (2). Asano Y; Kitamura S; Ohra T; Itoh F; Kajino M; Tamura T; Kaneko M; Ikeda S; Igata H; Kawamoto T; Sogabe S; Matsumoto S; Tanaka T; Yamaguchi M; Kimura H; Fukumoto S Bioorg Med Chem; 2008 Apr; 16(8):4699-714. PubMed ID: 18313930 [TBL] [Abstract][Full Text] [Related]
14. Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase. Maccari R; Ottanà R; Ciurleo R; Paoli P; Manao G; Camici G; Laggner C; Langer T ChemMedChem; 2009 Jun; 4(6):957-62. PubMed ID: 19288492 [TBL] [Abstract][Full Text] [Related]
15. Structural and stereoelectronic requirements for the inhibition of mammalian 2,3-oxidosqualene cyclase by substituted isoquinoline derivatives. Barth MM; Binet JL; Thomas DM; de Fornel DC; Samreth S; Schuber FJ; Renaut PP J Med Chem; 1996 Jun; 39(12):2302-12. PubMed ID: 8691425 [TBL] [Abstract][Full Text] [Related]
16. Activated Rac1, but not the tumorigenic variant Rac1b, is ubiquitinated on Lys 147 through a JNK-regulated process. Visvikis O; Lorès P; Boyer L; Chardin P; Lemichez E; Gacon G FEBS J; 2008 Jan; 275(2):386-96. PubMed ID: 18093184 [TBL] [Abstract][Full Text] [Related]
19. GTPase splice variants RAC1 and RAC1B display isoform-specific differences in localization, prenylation, and interaction with the chaperone protein SmgGDS. Koehn OJ; Lorimer E; Unger B; Harris R; Das AS; Suazo KF; Auger SA; Distefano MD; Prokop JW; Williams CL J Biol Chem; 2023 Jun; 299(6):104698. PubMed ID: 37059183 [TBL] [Abstract][Full Text] [Related]
20. Characterization of EHT 1864, a novel small molecule inhibitor of Rac family small GTPases. Onesto C; Shutes A; Picard V; Schweighoffer F; Der CJ Methods Enzymol; 2008; 439():111-29. PubMed ID: 18374160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]